The ACSR is committed to supporting the next generation of HIV researchers by offering a grant award program for early-stage investigators interested in conducting HIV-related research, especially for malignancies. The goal is to encourage novel and rigorous scientific research projects that utilize biospecimens and data in the ACSR inventory via a small grant funding mechanism and contribute toward greater understanding of HIV disease, biology, improved treatment, and discovery of a cure. See below to learn more about our Young Investigator Pilot Award opportunities as well as our past and current awardees. Click here to register for email updates about this and other HIV funding opportunities.
ACSR Funding Opportunities
MEET OUR YOUNG INVESTIGATOR PILOT AWARD AWARDEES!
- ACSR YOUNG INVESTIGATOR PILOT AWARD: FALL LOI CYCLE IS CLOSED! Please contact us for more information on upcoming cycles.
Other Funding Opportunities
Funding opportunities from non-ACSR sources.
- AIDS Malignancy Consortium: Closed to applications.
- American Association for Cancer Research:
- AACR-GENMAB NON-HODGKIN B-CELL LYMPHOMA RESEARCH FELLOWSHIP. Application Due Date: May 19, 2022
- National Institutes of Health (NIH) Funding Opportunity Announcements
- NOT-CA-22-031, Notice of Intent to Publish a Funding Opportunity Announcement for Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional). Application Due Date: July 30, 2022
- NOT-TW-22-001, Promoting Equity in Global Health Research, This Notice is a Request for Information (RFI) on approaches NIH can take to promote greater equity in global health research, particularly research that engages scientists in low and middle-income countries (LMICs) (REF). Response Date: August 01, 2022
- PAR-22-106, Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed), R03 Small Grant Program, Open Date (Earliest Submission Date), May 16, 2022
